Lanzamiento Enero 2027

Ensayo controlado aleatorizado2023

Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial

Ezpeleta M, Gabel K, Cienfuegos S, Kalam F, Lin S, Pavlou V, Song Z, Haus JM, Koppe S, Alexandria SJ, Tussing-Humphreys L, Varady KA

Cell metabolism · 143 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institutes of Health
Gobierno
National Cancer Institute
Gobierno
National Institute of Diabetes and Digestive and Kidney Diseases
Gobierno
NIDDK NIH HHS
Gobierno
NCI NIH HHS
Subvenciones
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-020572); National Cancer Institute (#T32CA193193); National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119783); National Institutes of Health (R01 DK119783)

Según 5 financiadores declarados.

Publicación

Publicado
2022-12-21 · Cell Metab · vol. 35 · número 1 · págs. 56–70.e3
Editorial
Cell Press
Citado
169 citas · más que el 100% de estudios similares · 19.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
112 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Liver Disease Diagnosis and Treatment · Dietary Effects on Health · Diet, Metabolism, and Disease
Palabras clave
non-alcoholic fatty liver disease, alternate-day fasting, intermittent fasting, aerobic exercise, hepatic steatosis, intrahepatic triglyceride, obesity, insulin sensitivity, lifestyle intervention, alanine aminotransferase, hepatokines
MeSH
liver, humans, body weight, triglycerides, exercise, fasting, adult, aged, middle aged, female, male, young adult, non-alcoholic fatty liver disease

12 autores

  • Mark Ezpeleta🇺🇸University of Illinois Chicago
  • Kelsey Gabel🇺🇸University of Illinois Chicago
  • Sofia Cienfuegos🇺🇸University of Illinois Chicago
  • Faiza Kalam🇺🇸University of Illinois Chicago
  • Shuhao Lin🇺🇸University of Illinois Chicago
  • Vasiliki Pavlou🇺🇸University of Illinois Chicago
  • Zhenyuan Song🇺🇸University of Illinois Chicago
  • Jacob M. Haus🇺🇸University of Michigan
  • Sean Koppe🇺🇸University of Illinois Chicago
  • Shaina J. Alexandria🇺🇸Northwestern University
  • Lisa Marie Tussing-Humphreys🇺🇸University of Illinois Chicago
  • Krista A Varady🇺🇸 · autor de correspondenciaUniversity of Illinois Chicago

Resumen

El texto original del estudio, en el idioma en que se publicó.

Innovative non-pharmacological lifestyle strategies to treat non-alcoholic fatty liver disease (NAFLD) are critically needed. This study compared the effects of alternate day fasting (ADF) combined with exercise to fasting alone, or exercise alone, on intrahepatic triglyceride (IHTG) content. Adults with obesity and NAFLD (n = 80, 81% female, age: 23-65 years) were randomized to 1 of 4 groups for 3 months: combination of ADF (600 kcal/2,500 kJ "fast day" alternated with an ad libitum intake "feast day") and moderate-intensity aerobic exercise (5 session per week, 60 min/session); ADF alone; exercise alone; or a no-intervention control group. By month 3, IHTG content was significantly reduced in the combination group (-5.48%; 95% CI, -7.77% to -3.18%), compared with the exercise group (-1.30%; 95% CI, -3.80% to 1.20%; p = 0.02) and the control group (-0.17%; 95% CI, -2.17% to 1.83%; p < 0.01) but was not significantly different versus the ADF group (-2.25%; 95% CI, -4.46% to -0.04%; p = 0.05). Body weight, fat mass, waist circumference, and alanine transaminase (ALT) levels significantly decreased, while insulin sensitivity significantly increased in the combination group compared with the control group. Lean mass, aspartate transaminase (AST), HbA1c, blood pressure, plasma lipids, liver fibrosis score, and hepatokines (fetuin-A, FGF-21, and selenoprotein P) did not differ between groups. Combining intermittent fasting with exercise is effective for reducing hepatic steatosis in patients with NAFLD but may offer no additional benefit versus fasting alone.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.